Staying abreast of regulations with NGS‑based viral safety for faster, safer and more ethical lot release of our vaccines - European Pharmaceutical Review

6/29/2022 12:00:00 AM2 years 10 months ago
Here, Sridhar Pennathur of Novavax highlights the value of next generation sequencing in their vaccine production operations.
Posted: 29 June 2022 | PathoQuest | No comments yet Here, Sridhar Pennathur, Vice President, Analytical Development at Novavax, highlights the value of next generation sequencing in their vaccine pr… [+6574 chars]
full article...